Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Databases in MS research: pitfalls and promises.

B G Weinshenker1

  • 1Department of Neurology, Mayo Clinic, 200 First Street, SW, Rochester, Minnesota, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|September 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of MOG antibody associated disorders: results of an international survey.

Journal of neurology·2020
Same author

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Journal of neurology, neurosurgery, and psychiatry·2019
Same author

[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Der Nervenarzt·2018
Same author

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Journal of neuroinflammation·2018
Same author

A population-based prospective study of optic neuritis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2017
Same author

Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.

Multiple sclerosis and related disorders·2015
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Prospective patient databasing in multiple sclerosis (MS) aids epidemiologic research and natural history studies. This method offers advantages over clinical trials for assessing long-term treatment effectiveness in broad populations.

Area of Science:

  • Neurology
  • Epidemiology
  • Data Science

Background:

  • Organized data repositories, or databases, are crucial for medical research.
  • Prospective collection of patient information (databasing) has been explored by multiple sclerosis (MS) consortia.
  • Databasing facilitates research into MS epidemiology and natural history, including treatment effects.

Purpose of the Study:

  • To explore the utility of prospective patient databasing in multiple sclerosis research.
  • To highlight the advantages of databasing over traditional clinical trials for assessing long-term treatment outcomes.
  • To address the limitations of databasing and propose strategies for overcoming them.

Main Methods:

  • Review of existing prospective patient databasing efforts in MS.

Related Experiment Videos

  • Comparative analysis of databasing versus clinical trials for therapeutic assessment.
  • Identification and discussion of challenges and solutions in MS databasing.

    • Main Results:

    • Databasing enables the study of long-term treatment effectiveness across diverse patient populations.
    • It offers a valuable complement to clinical trials, focusing on real-world data.
    • Limitations exist but can be mitigated through strategic approaches.

    Conclusions:

    • Prospective databasing is a valuable tool for advancing multiple sclerosis research.
    • It provides unique insights into disease progression and treatment efficacy in a real-world setting.
    • Addressing databasing limitations is key to maximizing its research potential.